• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

480 Biomedical

edit

480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). Its lead product, SFA scaffold, is a proprietary scaffold and delivery system for use in treating peripheral arterial disease in the SFA. The company was founded in 2011 and is based in Watertown, Massachusetts.

Recent Milestones

edit

• 
  480 Biomedical received $18M in Partial Close funding. (4/12/13)
  Posted 5/30/13 at 6:35am via sec.gov
• 
  480 Biomedical received $5M in Debt funding. (10/30/12)
  Posted 10/30/12 at 6:35pm via masshightech.com
• 
  480 Biomedical received $15M in Series A funding. (2/14/12)
  Posted 2/14/12 at 5:14am via onbiovc.com
• 
  480 Biomedical added Duke Collier as Chief Executive Officer.
  Posted 2/14/12 at 5:12am
• 
  480 Biomedical added Maria Palasis as Executive Vice President and Chief Technology Officer.
  Posted 2/14/12 at 5:12am
• 
  480 Biomedical added Ray Knox as Vice President, Operations.
  Posted 2/14/12 at 5:12am

Videos

Screenshots

edit

Above: 480 Biomedical
Uploaded: 2/14/12

Sources

1. 480 Biomedical, Inc.: Series A $15M (onbiovc.com) [edit]
2. 480 Biomedical gets $5M financing (masshightech.com) [edit]
3. SEC (sec.gov) [edit]